Stockscreener 앱 받기
4.38
4.16%
-0.19
시간 외 거래:
4.30
-0.08
-1.83%
전일 마감가:
$4.57
열려 있는:
$4.53
하루 거래량:
87,284
Relative Volume:
0.36
시가총액:
$48.57M
수익:
$52.29M
순이익/손실:
$-73.52M
주가수익비율:
-6.6364
EPS:
-0.66
순현금흐름:
$-100.45M
1주 성능:
-5.19%
1개월 성능:
-3.10%
6개월 성능:
-6.81%
1년 성능:
-48.23%
1일 변동 폭
$4.30
$4.66
1주일 범위
$4.30
$5.13
52주 변동 폭
$3.61
$11.09
Precision Biosciences Inc Stock (DTIL) Company Profile
명칭
Precision Biosciences Inc
전화
919-314-5512
주소
302 EAST PETTIGREW STREET, DURHAM, NC
DTIL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DTIL
Precision Biosciences Inc
|
4.38 | 53.33M | 52.29M | -73.52M | -100.45M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2024-04-30 | 개시 | Guggenheim | Buy |
| 2022-06-17 | 개시 | BMO Capital Markets | Outperform |
| 2022-06-09 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2020-07-27 | 재개 | BTIG Research | Buy |
| 2020-04-03 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-03-05 | 개시 | Stifel | Buy |
| 2020-02-25 | 개시 | William Blair | Outperform |
| 2019-08-09 | 개시 | BTIG Research | Buy |
| 2019-07-16 | 개시 | H.C. Wainwright | Buy |
| 2019-04-22 | 개시 | Barclays | Overweight |
| 2019-04-22 | 개시 | Goldman | Buy |
| 2019-04-22 | 개시 | JP Morgan | Overweight |
| 2019-04-22 | 개시 | Jefferies | Buy |
모두보기
Precision Biosciences Inc 주식(DTIL)의 최신 뉴스
Layoff Tracker: Bicycle, Tune, Iovance, Precision Downsize to Conserve Cash - BioSpace
Precision BioSciences (DTIL) Reports Q2 Loss, Lags Revenue Estimates - MSN
Applying Elliott Wave Theory to Precision BioSciences Inc.Algorithmic Forecast for Swing Trading Picks - Newser
Is Precision BioSciences Inc. stock entering bullish territorySafe Investment Ideas with Growth Upside - Newser
Precision BioSciences: Q2 Earnings Snapshot - Connecticut Post
Precision BioSciences Reports Significant Quarterly Loss - TipRanks
Precision BioSciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Precision BioSciences Reports Second Quarter 2025 Financial Results and Provides Business Update - BioSpace
Precision BioSciences Reports Second Quarter 2025 Financial Resu - GuruFocus
Precision BioSciences Announces Phase 1 Safety and Efficacy for Cohort 1, Lowest Dose Level in ELIMINATE-B, a First-In-Human Trial of PBGENE-HBV for Chronic Hepatitis B - Pipelinereview
Positive Outlook for Precision BioSciences Amid Promising Clinical Trial Data and Strategic Advancements - TipRanks
Precision BioSciences Reports Promising Phase 1 Trial Results - TipRanks
Precision BioSciences reports positive data for hepatitis B gene therapy By Investing.com - Investing.com Canada
Precision BioSciences Announces Phase 1 Safety and Efficacy for - GuruFocus
Using R and stats models for Precision BioSciences Inc. forecastingPredictive AI Engine for Smart Investing - Newser
Precision BioSciences Inc expected to post a loss of $1.57 a shareEarnings Preview - TradingView
Precision BioSciences to Report Second Quarter 2025 Results on August 7, 2025 - BioSpace
Precision BioSciences: A Strategic Play in the Gene Editing Revolution Amid Q2 Momentum and Regulatory Breakthroughs - AInvest
Precision BioSciences Inc. Stock Analysis and ForecastRemarkable growth - Jammu Links News
Is Precision BioSciences Inc. stock overvalued or undervaluedGet exclusive market insights for better trading - Jammu Links News
What institutional investors are buying Precision BioSciences Inc. stockInvest in stocks with long-term growth potential - Jammu Links News
What is Precision BioSciences Inc. company’s growth strategyRealize consistent double-digit growth - Jammu Links News
Does Precision BioSciences Inc. stock perform well during market downturnsCapitalize on high-growth stocks early - Jammu Links News
When is Precision BioSciences Inc. stock expected to show significant growthMaximize profits with strategic stock selection - Jammu Links News
Using data filters to optimize entry into Precision BioSciences Inc.Free Real-Time Market Sentiment Tracking Tool - Newser
What are the latest earnings results for Precision BioSciences Inc.Achieve rapid portfolio appreciation today - Jammu Links News
What catalysts could drive Precision BioSciences Inc. stock higher in 2025Capitalize on high-growth stocks early - Jammu Links News
Is it the right time to buy Precision BioSciences Inc. stockUnprecedented market success - Jammu Links News
Published on: 2025-08-03 13:05:53 - Jammu Links News
What are analysts’ price targets for Precision BioSciences Inc. in the next 12 monthsFind the best stocks for sustainable growth - Jammu Links News
Should I hold or sell Precision BioSciences Inc. stock in 2025Real Time Tracker For Fast Growth - Jammu Links News
Precision Biosciences shares fall 2.11% intraday as Illumina reports Q2 revenue drop. - AInvest
Published on: 2025-07-29 15:58:11 - metal.it
Why Precision BioSciences Inc. stock attracts strong analyst attentionFast Return Equity Trade Forecast Points to Small Caps - metal.it
Precision BioSciences Inc. Stock Lags Behind Sector BenchmarksReal Time Trade Opportunity Alerts Monitor Market Surges - beatles.ru
What are the technical indicators suggesting about Precision BioSciences Inc.Explosive capital appreciation - Jammu Links News
How does Precision BioSciences Inc. generate profit in a changing economyBuild wealth steadily with smart trading - Jammu Links News
What are Precision BioSciences Inc. company’s key revenue driversBuild wealth steadily with expert advice - Jammu Links News
How Precision BioSciences Inc. stock performs during market volatilityInvestor Favorite Picks - metal.it
Precision Biosciences Inc (DTIL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):